Paper17513808
Microsatellite instability and epigenetic inactivation of MLH1 and outcome of patients with endometrial carcinomas of the endometrioid type.
Zighelboim I and 6 others. J Clin Oncol, 2007. Cited by 175 papers, by iCite.
Cite this record
ConductScience Library. Microsatellite instability and epigenetic inactivation of MLH1 and outcome of patients with endometrial carcinomas of the endometrioid type. Papers, record 17513808. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17513808
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adaptor Proteins, Signal Transducing | Major topic |
| Carcinoma, Endometrioid | Major topic |
| DNA Methylation | Major topic |
| Endometrial Neoplasms | Major topic |
| Epigenesis, Genetic | Major topic |
| Microsatellite Instability | Major topic |
| Nuclear Proteins | Major topic |
| Cohort Studies | |
| DNA Repair | |
| Female | |
| Humans | |
| Microsatellite Repeats | |
| Middle Aged | |
| MutL Protein Homolog 1 | |
| MutS Homolog 2 Protein | |
| Polymerase Chain Reaction | |
| Prospective Studies |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P30 CA91842 | NCI NIH HHS | United States | P30CA091842 | PubMed and NIH | NIH RePORTER |
| R01 CA71754 | NCI NIH HHS | United States | R01CA071754 | PubMed and NIH | NIH RePORTER |
Cited by95
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 175 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41976325 | Feasibility of TP53-Mutated ctDNA Monitoring in High-Grade Endometrial Cancer Using Routine NGS. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/41976325 | PubMed |
| 41918736 | Does immunotherapy hold great promise in endometrial cancer care? | Front Immunol | 2026 | https://conductscience.org/library/papers/41918736 | PubMed |
| 40878396 | The relationship between histopathological data and molecular alterations with oncological outcomes in endometrioid-type endometrial cancers and a novel POLE mutation. | J Gynecol Oncol | 2026 | https://conductscience.org/library/papers/40878396 | PubMed |
| 40657367 | Mismatch Repair Protein Deficiency and Its Relationship with Clinicopathological Factors in Endometrial Cancer: A Retrospective Study. | J Cancer | 2025 | https://conductscience.org/library/papers/40657367 | PubMed |
| 40149367 | Trends in Endometrial Cancer Incidence Among Premenopausal and Postmenopausal Women in the United States Between 2001 and 2021. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40149367 | PubMed |
| 40141259 | MiR-205-5p and MiR-222-3p as Potential Biomarkers of Endometrial Cancer. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40141259 | PubMed |
| 39301379 | Clinicopathological Significance of Defective DNA Mismatch Repair in Endometrial Carcinoma: A Single-Center Study From Bahrain. | Cureus | 2024 | https://conductscience.org/library/papers/39301379 | PubMed |
| 39220299 | Molecular classification of endometrial cancer: preliminary experience from a single Portuguese academic center. | Pathol Oncol Res | 2024 | https://conductscience.org/library/papers/39220299 | PubMed |
| 39020532 | Prognostic implications of immunohistochemistry in patients with endometrial cancer. | Rom J Morphol Embryol | 2024 | https://conductscience.org/library/papers/39020532 | PubMed |
| 38539494 | Biomarkers in the Diagnosis of Endometrial Precancers. Molecular Characteristics, Candidate Immunohistochemical Markers, and Promising Results of Three-Marker Panel: Current Status and Future Directions. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/38539494 | PubMed |
| 38318760 | Role of INPP4B in the proliferation, migration, invasion, and survival of human endometrial cancer cells. | Histol Histopathol | 2024 | https://conductscience.org/library/papers/38318760 | PubMed |
| 37765210 | Targeting DNA Damage Repair and Immune Checkpoint Proteins for Optimizing the Treatment of Endometrial Cancer. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/37765210 | PubMed |
| 37509300 | Retrospective Analysis of the Correlation of MSI-h/dMMR Status and Response to Therapy for Endometrial Cancer: RAME Study, a Multicenter Experience. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37509300 | PubMed |
| 37422672 | Clear cell endometrial carcinoma with high microsatellite instability in a complicated pregnancy: a case report. | J Med Case Rep | 2023 | https://conductscience.org/library/papers/37422672 | PubMed |
| 37190216 | Microsatellite Instability: A Review of Molecular Epidemiology and Implications for Immune Checkpoint Inhibitor Therapy. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37190216 | PubMed |
| 37146405 | Single-cell profiling of low-stage endometrial cancers identifies low epithelial vimentin expression as a marker of recurrent disease. | EBioMedicine | 2023 | https://conductscience.org/library/papers/37146405 | PubMed |
| 36979434 | Novel Insights into Molecular Mechanisms of Endometrial Diseases. | Biomolecules | 2023 | https://conductscience.org/library/papers/36979434 | PubMed |
| 36833105 | Role of Genomic and Molecular Biology in the Modulation of the Treatment of Endometrial Cancer: Narrative Review and Perspectives. | Healthcare (Basel) | 2023 | https://conductscience.org/library/papers/36833105 | PubMed |
| 36377723 | Complete pathological response following chemotherapy and radiotherapy in two cases of advanced anaplastic thyroid carcinoma. | Eur Thyroid J | 2023 | https://conductscience.org/library/papers/36377723 | PubMed |
| 36348114 | Epigenetic-Mediated Regulation of Gene Expression for Biological Control and Cancer: Cell and Tissue Structure, Function, and Phenotype. | Results Probl Cell Differ | 2022 | https://conductscience.org/library/papers/36348114 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| MLH1 | 4292 | PubTator's text mining | https://conductscience.org/library/genes/4292 | NCBI Gene |
| MSH2 | 4436 | PubTator's text mining | https://conductscience.org/library/genes/4436 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17513808
GET https://conductscience.org/api/papers/v1/17513808/cited_by?page=2